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doi:10.1016/j.pedneo.2012.04.002Background: Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heart
disease in which the connection between the pulmonary vein (PV) and left atrium needs to be
surgically created. This study investigated the spectrum and outcome of a Taiwanese cohort.
Methods: Isolated TAPVC cases were identified from our institutional database between 1995
and 2009. We reviewed the medical chart and conducted telephone interviews with those lost
to follow-up.
Results: There were 78 patients (52% male). The anomalous drainage sites were mainly supra-
cardiac type (42.3%) and cardiac type (39.8%). Before operation, PV stenosis was found in 100%
of infracardiac type, and in 69.7% of supracardiac type. Among the 75 patients undergoing
operation, the surgical mortality was 9% (7/75). Perioperative arrhythmias (mainly of atrial
origin) occurred in 35% of the patients. Of the 68 patients who survived the first operation,
28 (41%) developed pulmonary vein restenosis. Half of them progressed to severe PV stenosis,
which required reintervention or resulted in mortality. Preoperative PV stenosis was the most
significant predictor for postoperative PV restenosis and PV re-intervention. For the cohort,
the 1-year and 5-year survivals were 78.9% and 74.2%, respectively, and the predictor for
survival was again preoperative PV stenosis.of Pediatrics, National Taiwan University Hospital, No. 7, Chung-Shan S. Rd., Taipei 100, Taiwan.
(M.-H. Wu).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
Surgical outcomes of TAPVC 165Conclusion: The surgical mortality of isolated TAPVC is now low. Preoperative PV stenosis not
only increased the risk of late PV restenosis and its reintervention, but also the overall
mortality. The spectrum of PV drainage, per se, was not associated with worse outcome. PV
restenosis remained the most important issue after correction of TAPVC.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Total anomalous pulmonary venous connection (TAPVC) is
a rare congenital heart disease, in which pulmonary veins
are connected to an abnormal location rather than the left
atrium. It accounts for 1% to 3% of congenital heart disease
according to Western reports.1e4 The incidence in Taiwan is
0.11/1000 live births, which accounts for 0.8% of the
congenital heart diseases.5 Since the diagnosis is only rarely
made at the fetal stage, the incidence has not changed
greatly in recent years. Patients usually develop progres-
sive pulmonary congestion and low cardiac output, and the
severity is dependent on the condition of pulmonary venous
obstruction (PVO) and the restriction of interatrial
communication. Without surgical correction, the prognosis
is extremely poor, with a mortality of 80% during infancy.6,7
With advances in cardiac surgery, the surgical mortality is
now in generally below 10%.1,8 However, pulmonary vein
(PV) restenosis may appear after the cardiac repair and
may be difficult to manage.2 This study, based on the 15-
year experience of a tertiary medical center in Taiwan,
a country with child health index similar to that of the
USA,9 investigated the clinical spectrum of Asian population
as well as the predictors of outcomes.2. Materials and Methods
This study was approved by the institutional review
committee of National Taiwan University Hospital, and
individual informed consent was waived due to the retro-
spective nature of the study. Patients with TAPVC were
identified from the database of National Taiwan University
Hospital from January 1995 to June 2009. The classification
of TAPVC was based on that proposed by Darling and asso-
ciates in 1957 as supracardiac, cardiac, infracardiac, and
mixed types.10 Only cases of isolated TAPVC were enrolled.
Except for patent ductus arteriosus, atrial septal defect
(ASD), and patent foramen ovale, patients with other
associated anomalies (e.g. ventricular septal defect,
coarctation of aorta, heterotaxy syndrome, or single
ventricular circulation, etc) were excluded from this study.
The diagnosis was mainly made by echocardiography. In
earlier years, the diagnosis of TAPVC was also confirmed by
cardiac catheterization. PVO was defined as peak pulmo-
nary venous flow 1.5 m/s (roughly equal to pressure
gradient 9 mmHg)11 measured by echocardiography pulse
wave Doppler or confirmed by cardiac catheterization,
computed tomography (CT; 50% or more narrowing in
diameter of PV was considered as PVO), or surgical finding.
Of the TAPVC patients, all underwent echocardiographystudy, 34 were diagnosed only by echocardiography, 22 had
additional cardiac CT study, 14 had additional cardiac
catheterization study, and 8 had both cardiac CT and
cardiac catheterization. Surgical mortality was defined as
mortality within 1 month of operation. Patients’ medical
charts were reviewed, and clinical data collected for
statistical analysis. For patients who were lost to follow-up,
a telephone interview was performed if possible.
2.1. Statistics
SPSS software was used for statistical analysis. Differences
of numeric variables were compared using Fisher’s exact
and Chi-square tests. Probability of survival after operation
was calculated and plotted by Kaplan-Meier method.
Logistic and Cox regression analyses were used for multi-
variate analysis in binary endpoint and time table analyses,
respectively. A p-value <0.05 was considered statistically
significant.3. Results
A total of 239 patients were diagnosed with TAPVC.
Excluding those associated with other major cardiac
anomalies, 78 patients with isolated TAPVC were enrolled
into this study. The total follow-up period was 409 patient-
years. The basic characteristics of the 78 patients were as
follows: the female-to-male ratio was 38 to 41, prematurity
accounting for 12.7% (10/79) of the patients. Excluding one
patient who underwent cardiac repair at the age of 37
years, the median (mean  SD) ages of symptom presen-
tation and diagnosis were 1 day (18  38) and 9 days
(38  57), respectively. The initial presentations included
cyanosis (57%), respiratory distress (43%) and poor activity/
appetite (23%). The median age at operation was 24 days
(52  61), with median body weight of 3232 gm
(3490  1104). As shown in Table 1, the most common type
of TAPVC was supracardiac (33/78, 42.3 %), followed by
cardiac (31/78, 39.8%; among them, 64% had drainage to
the coronary sinus, and 32% to the right atrium directly).
The mixed type was the least common (4/78, 5.1%); two
were combination of supracardiac-cardiac type, and two
were mixed supracardiac-infracardiac type. Preoperative
PVO was present in 57.7% (45/78) of patients, and most
common in the infracardiac type (100%) and least common
in the cardiac type (29%).
The flow chart of the clinical events of this cohort is
displayed in Figure 1. Of the 78 patients, three did not
undergo surgical repair due to family’s choice, and all died
within one day of diagnosis. For the remaining 75 patients,
Table 1 Sites of pulmonary venous connection and asso-
ciated pulmonary venous obstruction.
Site of connection Number of
patients (%)
Number with
obstruction (%)
Supracardiac 33 (42.3%) 23 (69.7%)
Innominate vein 22 (28.2%) 15 (68.2%)
Superior vena cava 11 (14.1%) 8 (72.7%)
Cardiac 31 (39.8%) 9 (29%)
Right atrium 10 (12.8%) 2 (20.0%)
Coronary sinus 20 (25.6%) 6 (30.0%)
Not available 1 1
Infracardiac 10 (12.8%) 10 (100%)
Mixed 4 (5.1%) 3 (75.0%)
Supracardiac þ
infracardiac
2 (2.6%) 2 (100%)
Supracardiac þ cardiac 2 (2.6%) 1 (50.0%)
Total 78 (100%) 45 (57.7%)
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9.3%); four of poor ventricular function (within 1 day after
operation), one died of cardiac tamponade (1 day after
operation), and two of PVO and pulmonary hypertensive
crisis (at 12 and 15 days after operation, respectively).
The surgical mortality was 14.3% (6/42) in the group
with preoperative PVO but 3.2% (1/31) in the group
without preoperative PVO, without statistical significance
(p Z 0.113). Also, the surgical mortality was 13.3% (6/45)
during 1995 to 2000 and 3% (1/30) during 2001 to 2009, but
no significant difference was identified statistically
(p Z 0.145), either.Figure 1 Summary of the outcomTwenty-six patients (35%, 26/74) undergoing total
correction developed arrhythmia, including sinus brady-
cardia, atrial fibrillation/flutter, ectopic atrial tachycardia,
supraventricular tachycardia, atrial premature contraction,
atrioventricular (AV) block, ventricular premature
contraction, and ventricular tachycardia. Atrial arrythmia
accounted for most of the episodes (57.6%, 15/26). Eight
had medical control initially, and two of them experienced
late mortality because of repeated respiratory infection.
Other patients discontinued antiarrhythmic agents during
follow-up (at 3 months to 12 months after operation)
without recurrence of the arrhythmias. Seven patients
were recorded to have sinus bradycardia. Of them, three
were caused by poor postoperative ventricular function,
and they died within one month after operation. Transient
bradycardia developed in another four patients without
symptoms or the need for pacemaker implantation. Five
patients developed first- or second-degree AV block (no
complete AV block) and, of them, only one underwent
permanent pacemaker implantation. All were doing well at
the follow-up. Ventricular arrhythmias seldom occurred in
this cohort, with only two patients with ventricular
premature contraction and one patient with ventricular
tachycardia during the immediate postoperative period.
The ventricular arrhythmias were controlled medically and
resolved at follow-up.
PV restenosis developed in 28 (41%) patients during the
follow-up. As shown in Figure 2, the freedom from PV
restenosis decreased rapidly within the first post-
operative year and remained stationary in the subsequent
years. The rates of freedom from PV restenosis were
63.2%, 55.3%, and 55.3% at 1 year, 5 years, and 10 years
after the first TAPVC repair, respectively. Among the 28es of the patients of this study.
Figure 2 (A) Kaplan-Meier event-free curves to show the rates of freedom from PV restenosis, which were 63.2% at 1 year, 55.3%
at 5 years, and 55.3% at 10 years after operation. (B) Kaplan-Meier event-free curves to show the freedom from PV restenosis in
patients further categorized by without (B) or with (6) preoperative PVO, p Z 0.003.
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restenosis and 10 survived the postoperative course.
During follow-up, however, only six showed clinical
improvement and long-term survival. Multivariate Cox
regression showed that the preoperative PVO was the
only significant predictor for the development of PV
restenosis (Table 2). Reintervention of PV stenosis was
performed for those with significant symptoms. The
freedom from PV reintervention is shown in Figure 3.
The trend of each curve was similar to that of restenosis.
The difference at 10 years after the initial operation was
due to a late intervention on the restenosis for a patient
with cardiac TAPVC. Nonetheless, preoperative PVO was
still identified as the only significant predictor for PV
reintervention, with p Z 0.056.
There were nine (13%) late deaths. One died of recurrent
respiratory infection and refractory arrhythmia without PV
restenosis. The other 8 patients had PV restenosis. Among
them, two died of pneumonia, and six underwent an
unsuccessful pulmonary vein revision operation. One also
received repeated surgical PV revision, balloon angioplasty,
and PV stenting for the pulmonary veins (a total of 6
interventions after the initial operation), but PV stenosis
still recurred and resulted in low cardiac output and
mortality. The one-year and 5-year survivals were 78.9%
and 74.2% (by Kaplan-Meier analysis), respectively
(Figure 4). By multivariate Cox regression, preoperative
PVO was identified as the only predictor for long-term
survival (Table 2).4. Discussion
From this TAPVC patient cohort from a tertiary care center
in Taiwan, we have the following main findings: (1) the
most common type was supracardiac, followed by cardiac
and infracardiac;( 2) with surgical advances, the surgical
mortality was 3% in the most recent decade; and (3)
preoperative PVO was the only significant predictor for notonly postoperative PV restenosis and the requirement of PV
reintervention, but also long-term survival.
Supracardiac TAPVC is the most common type reported,
accounting for about 40% to 45% of the total.1e3 Our study
echoed these observations, with cardiac type as the second
most common type. In contrast, in some series, infracardiac
type was the second most common type, accounting for
about 20% to 26%.1e3,12 Our study showed no association
between the type of TAPVC and risk of mortality or long-
term survival. But previous studies showed no consistent
results,1e3,8,12 and the relationhips between the types of
TAPVC and outcome are still controversial.
Some patients with TAPVC, particularly the infracardiac
(100%), mixed (75%) and supracardiac (69.7%) types, may
have associated PVO. The diagnosis of PVO is usually
achieved by echocardiography, with fair sensitivity and
specificity.11,13 Continuous and accelerated pulmonary
flow with nonphasic flow pattern is indicative of PVO. The
obstruction may be caused by extrinsic pressures or
intrinsic narrowing of the vein, or both.14 Previous studies
showed that PVO might be present in 25% to 50% of TAPVC
cases at initial diagnosis.1,2,8,11,12 While the presence of
preoperative PVO did not increase the risk of surgical
mortality, it was the only significant predictor for long-
term mortality and postoperative PV restenosis and its
reintervention.
Corrective surgery for patients with TAPVC should be
performed as soon as possible. In earlier reports, low body
weight, young age, and prematurity were associated with
a higher mortality at cardiac surgery. But in their study,
Bove´ et al found that these factors were no greater risk
factors for surgery, and such observation has also been
described in other reports.1,6,8,15,16 In Taiwan, a successful
surgical correction of cardiac type TAPVC in a baby with
very low birth weight, 1250 g, at age 20 days, was reported,
supporting the feasibility of early surgical correction of
TAPVC.17 In our study, the body weight and age at operation
were not associated with increased risk for surgical or long-
term mortality, either.
Table 2 Risk factors of surgical mortality, overall mortality, pulmonary vein restenosis, and pulmonary vein reintervention.
Outcome Variable Univariable p value Cox multivariate analysis
Hazard ratio (95% CI) p value
Surgical mortality Gender 0.611 d d d
Prematurity 0.837 d d d
TAPVC type 0.255 d d d
Preoperative PVO 0.113 d d d
Before vs after 2001 0.145 d d d
Age at presentation 0.453 d d d
Age at diagnosis 0.697 d d d
Age at operation 0.759 d d d
BW at operation 0.721 d d d
Overall mortality Gender 0.747 d d d
Prematurity 0.720 d d d
TAPVC type 0.016* d d 0.547
Preoperative PVO 0.013* 0.178 0.04e0.792 0.023
Before vs after 2001 0.149 d d d
Age at presentation 0.649 d d d
Age at diagnosis 0.228 d d d
Age at operation 0.452 d d d
BW at operation 0.158 d d d
PV restenosis Gender 0.67 d d d
Prematurity 0.15 d d d
TAPVC type 0.040* d d 0.125
Preoperative PVO 0.002* 0.151 0.052e0.441 0.003
Before vs after 2001 0.027* d d 0.325
Age at presentation 0.054* d d 0.199
Age at diagnosis 0.130 d d d
Age at operation 0.451 d d d
BW at operation 0.276 d d d
PV reintervention Gender 0.144 d d d
Prematurity 0.129 d d d
TAPVC type 0.131 d d d
Preoperative PVO 0.037* 0.224 0.048e1.041 0.056
Before vs after 2001 0.322 d d d
Age at presentation 0.479 d d d
Age at diagnosis 0.710 d d d
Age at operation 0.644 d d d
BW at operation 0.546 d d d
BW Z body weight; PV Z pulmonary vein; PVO Z pulmonary venous obstruction; TAPVC Z total anomalous pulmonary venous
connection.
* Significant in univariate analysis, and collected to be analyzed in multivariate analysis.
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10% to 80%,1,7,15 but most recent reports revealed a surgical
mortality <10%.1,2,8 Our surgical mortality was 9.3% and
was even down to 3% in the latest decade. This figure is
quite comparable to those in previous reports and was in
the lower range of mortality. We did not identify any
significant predictor for surgical mortality in this isolated
TAPVC cohort, although there was a trend of higher surgical
mortality for preoperative PVO and early surgical era. In
the report by Bando et al, preoperative PVO and pulmonary
hypertension was associated with higher surgical mortality
in the early surgical era, but the correlation was unap-
parent after 1991.18 Another report also demonstrated
preoperative PVO as a predictor of surgical mortality only in
TAPVC with single ventricle physiology, but not in two-
ventricle patients.15 But in Morales et al’s study,preoperative PVO was not a risk factor for surgical
mortality, even in heterotaxy patients.8 The wide spectrum
of TAPVC and PVO in patients with heterotaxy may account
for such discrepancy.
In our study, 28 patients who survived the first operation
developed PV restenosis and 12 patients received reinter-
vention. The rate of freedom from PV reintervention was
85.6% at 1 year and 80.7% at 5 years after operation, indi-
cating reintervention occurred mainly within 1 year after
total correction. In previous studies, better results, with
freedom from reintervention of 92% to 99% at 1 year, were
reported.8,15 The results of reintervention for PVO remain
unsatisfactory. After pulmonary venous orifice revision, PV
restenosis was common, and the outcome was poor.19
Lacout-Gayet et al advocated sutureless in situ pericar-
dium repair for PVO and suggested that it may offer
Figure 3 (A) Kaplan-Meier event-free curves to show the rates of freedom from PV reintervention, which were 85.6% at 1 year,
80.7% at 5 years, and still 80.7% at 10 year after operation. (B) Kaplan-Meier event-free curves to show the freedom from PV
reintervention in patients further categorized by without (B) or with (6) preoperative PVO, with p Z 0.056.
Surgical outcomes of TAPVC 169a better outcome.20,21 Balloon dilatation of the PV may
provide only temporary relief from obstruction. Stent
implantation may be effective, but neointimal proliferation
is likely to develop and lead to in-stent stenosis during
follow-up.2,22,23 In our series, one patient with infracardiac
TAPVC developed recurrent PV restenosis after cardiac
repair and multiple interventions, including surgical PV
revision, intraoperational stenting, transcatheter stenting,
and balloon angioplasty; the patient still died of low
cardiac output as the result of recurrent PV stenosis.
We have identified preoperative PVO as the only risk
factor for long-term mortality. Our study did not enroll
patients with heterotaxy or single-ventricle physiology,
which are important predictors for the outcome of TAPVC
patients.3 Not every study showed the relationship between
preoperative PVO and long-term mortality.1,3 SuchFigure 4 (A) Kaplan-Meier event-free curves to show the overall s
operation. Mortality mainly occurred during first year after opera
survival in patients further categorized by without (B) or with (6discrepancy may be due in part to the definition of PVO of
each study. Significant PVO usually needs to be relieved and
may be associated with longer cardiopulmonary bypass
time. Therefore, we suggest that preoperative PVO is an
important predictor for long-term mortality in patients with
isolated TAPVC.
A limitation of this study was that it did not analyze the
effect of ASD size, partially because of the lack of definition
of ASD restriction and some borderline descriptions in chart
records. But ASD restriction may contribute to preoperative
pulmonary hypertension and has been supposed to be
related to the preoperative condition.24 As mentioned
above, single- ventricle physiology should be an important
factor for outcome of TAPVC. Further study to clarify and
compare the clinical course of TAPVC with single- and two-
ventricle physiology is necessary.urvivals, which were 78.9% at 1 year and 74.2% at 5 years after
tion. (B) Kaplan-Meier event-free curves to show the overall
) preoperative PVO, with p Z 0.023.
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The surgical mortality of isolated TAPVC is now low and was
only 3.2% in the latest decade, as shown in this patient
cohort from a tertiary care center of Taiwan. The preop-
erative PV stenosis not only increased the risk of late PV
restenosis and its reintervention, but also was associated
with higher overall mortality at follow-up. The spectrum of
PV drainage, most commonly to supracardiac, followed by
cardiac, infracardiac and mixed sites, was not associated
per se with worse outcome. PV restenosis remains the most
important issue after correction of TAPVC.References
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